Abstract
Aging is accompanied by several age-related disorders leading to death of living beings. These age-related disorders and pathological conditions may also include the development of cancer. Cancer is a chronic disease, and many changes at cellular, molecular, and physiological levels that occur during aging affect the biology of cancer. There are several phenomena which are common between cancer and aging such as telomere shortening, genomic instability, senescence, global hypomethylation, promoter-specific hypermethylation, metabolism, and autophagy. Hence, the association between biology of cancer and aging is incontrovertible; however, the underlying molecular mechanisms could be similar or different. Understanding the common cellular and molecular biology of stem and progenitors cells in cancer and aging will undoubtedly help in exploring novel targets that could be used as a therapy and thus can improve the early detection and treatment of aging-associated pathologies such as cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lees H, Walters H, Cox LS. Animal and human models to understand ageing. Maturitas. 2016;93:18–27.
López-OtÃn C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–217.
Jin K. Modern biological theories of aging. Aging Dis. 2010;1:72–4.
Weinert BT, Timiras PS. Invited review: theories of aging. J Appl Physiol. 2003;95:1706.
Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013;75:685–705.
Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007;130:223–33.
Rufini A, Tucci P, Celardo I, Melino G. Senescence and aging: the critical roles of p53. Oncogene. 2013;32:5129–43.
Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol. 2011;192:547–56.
Mitchell SJ, Scheibye-Knudsen M, Longo DL, de Cabo R. Animal models of aging research: implications for human aging and age-related diseases. Annu Rev Anim Biosci. 2015;3:283–303.
Cruickshanks HA, Adams PD. Chromatin: a molecular interface between cancer and aging. Curr Opin Genet Dev. 2011;21:100–6.
Yancik R, Ries LA. Cancer in older persons: an international issue in an aging world. Semin Oncol. 2004;31:128–36.
Frank SA. Dynamics of cancer: incidence, inheritance, and evolution. Princeton NJ: Steven A Frank; 2007.
Anisimov VN. Carcinogenesis and aging 20 years after: escaping horizon. Mech Ageing Dev. 2009;130:105–21.
Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol Off J Eur Soc Med Oncol. 2001;12:997–1003.
Ershler WB, Stewart JA, Hacker MP, Moore AL, Tindle BH. B16 murine melanoma and aging: slower growth and longer survival in old mice. J Natl Cancer Inst. 1984;72:161–4.
Balducci L, Ershler WB. Cancer and ageing: a nexus at several levels. Nat Rev Cancer. 2005;5:655–62.
Finkel T, Serrano M, Blasco MA. The common biology of cancer and ageing. Nature. 2007;448:767–74.
de Magalhaes JP. How ageing processes influence cancer. Nat Rev Cancer. 2013;13:357–65.
Serrano M, Blasco MA. Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol. 2007;8:715–22.
Campisi J, Yaswen P. Aging and cancer cell biology, 2009. Aging Cell. 2009;8:221–5.
Kudryavtseva AV, Krasnov GS, Dmitriev AA, Alekseev BY, Kardymon OL, Sadritdinova AF, et al. Mitochondrial dysfunction and oxidative stress in aging and cancer. Oncotarget. 2016;7:44879–905.
Das PM, Singal R. DNA methylation and cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:4632–42.
Fraga MF, Agrelo R, Esteller M. Cross-talk between aging and cancer: the epigenetic language. Ann N Y Acad Sci. 2007;1100:60–74.
Campisi J. Cancer and ageing: rival demons? Nat Rev Cancer. 2003;3:339–49.
Anisimov VN. The relationship between aging and carcinogenesis: a critical appraisal. Crit Rev Oncol Hematol. 2003;45:277–304.
Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–217.
Vogel H, Lim DS, Karsenty G, Finegold M, Hasty P. Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci U S A. 1999;96:10770–5.
Augert A, Bernard D. Immunosenescence and senescence immunosurveillance: one of the possible links explaining the cancer incidence in ageing population. In: Wang Z, Inuzuka H, editors. Senescence and senescence-related disorders. Rijeka: InTech; 2013.. p Ch. 04.
Kong Y, Cui H, Ramkumar C, Zhang H. Regulation of senescence in cancer and aging. J Aging Res. 2011;2011:963172.
Falandry C, Bonnefoy M, Freyer G, Gilson E. Biology of cancer and aging: a complex association with cellular senescence. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32:2604–10.
Anisimov VN. Biology of aging and cancer. Cancer control: J Moffitt Cancer Cent. 2007;14:23–31.
Ershler WB, Longo DL. Aging and cancer: issues of basic and clinical science. J Natl Cancer Inst. 1997;89:1489–97.
Johnson AA, Akman K, Calimport SR, Wuttke D, Stolzing A, de Magalhaes JP. The role of DNA methylation in aging, rejuvenation, and age-related disease. Rejuvenation Res. 2012;15:483–94.
Lin Q, Wagner W. Epigenetic aging signatures are coherently modified in cancer. PLoS Genet. 2015;11:e1005334.
Rakyan VK, Down TA, Maslau S, Andrew T, Yang T-P, Beyan H, et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res. 2010;20:434–9.
Anisimov VN. Biology of aging and Cancer. Cancer Control. 2017;14(1):23–31.
Xie B, Chen J, Liu B, Zhan J. Klotho acts as a tumor suppressor in cancers. Pathol Oncol Res: POR. 2013;19:611–7.
Rubinsztein DC, Marino G, Kroemer G. Autophagy and aging. Cell. 2011;146:682–95.
Gerl R, Vaux DL. Apoptosis in the development and treatment of cancer. Carcinogenesis. 2005;26:263–70.
Blagosklonny MV. Selective anti-cancer agents as anti-aging drugs. Cancer Biol Ther. 2013;14:1092–7.
Malaguarnera L, Ferlito L, Di Mauro S, Imbesi RM, Scalia G, Malaguarnera M. Immunosenescence and cancer: a review. Arch Gerontol Geriatr. 2001;32:77–93.
Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest. 2007;117:1137–46.
Carlson ME, Silva HS, Conboy IM. Aging of signal transduction pathways, and pathology. Exp Cell Res. 2008;314:1951–61.
Kaur A, Webster MR, Weeraratna AT. In the Wnt-er of life: Wnt signalling in melanoma and ageing. Br J Cancer. 2016;115:1273–9.
Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P, et al. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY). 2011;3:192–222.
Wang X. Microarray analysis of ageing-related signatures and their expression in tumors based on a computational biology approach. Genomics Proteomics Bioinformatics. 2012;10:136–41.
Wang X. Discovery of molecular associations among aging, stem cells, and cancer based on gene expression profiling. Chin J Cancer. 2013;32:155–61.
Ahmad A, Banerjee S, Wang Z, Kong D, Majumdar AP, Sarkar FH. Aging and inflammation: etiological culprits of cancer. Current Aging Sci. 2009;2:174–86.
Cui H, Kong Y, Zhang H. Oxidative stress, mitochondrial dysfunction, and aging. J Signal Transduction. 2012;2012:646354.
Afanas’ev I. Reactive oxygen species signaling in cancer: comparison with aging. Aging Dis. 2011;2:219–30.
Fulop T, Larbi A, Kotb R, de Angelis F, Pawelec G. Aging, immunity, and cancer. Discov Med. 2011;11:537–50.
Rodier F, Campisi J, Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Res. 2007;35:7475–84.
Hasty P, Christy BA. p53 as an intervention target for cancer and aging. Pathobiol Aging Age Relat Dis. 2013;3:1–11.
Lanning NJ, Carter-Su C. Recent advances in growth hormone signaling. Rev Endocr Metab Disord. 2006;7:225–35.
Bartke A. Growth hormone and aging: a challenging controversy. Clin Interv Aging. 2008;3:659–65.
Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 2003;421:182–7.
Anisimov VN, Bartke A. The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer. Crit Rev Oncol Hematol. 2013;87:201–23.
Efeyan A, Comb WC, Sabatini DM. Nutrient-sensing mechanisms and pathways. Nature. 2015;517:302–10.
Santos J, Leitao-Correia F, Sousa MJ, Leao C. Dietary restriction and nutrient balance in aging. Oxidative Med Cell Longev. 2016;2016:4010357.
Gallinetti J, Harputlugil E, Mitchell JR. Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR. Biochem J. 2013;449:1–10.
Menon S, Manning BD. Cell signalling: nutrient sensing lost in cancer. Nature. 2013;498:444–5.
Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell. 2008;132:681–96.
Singh SR. Stem cell niche in tissue homeostasis, aging and cancer. Curr Med Chem. 2012;19:5965–74.
Adams PD, Jasper H, Rudolph KL. Aging-induced stem cell mutations as drivers for disease and cancer. Cell Stem Cell. 2015;16:601–12.
Hiyama E, Hiyama K. Telomere and telomerase in stem cells. Br J Cancer. 2007;96:1020–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Rajput, M., Dwivedi, L., Sabarwal, A., Singh, R.P. (2020). The Biology of Aging and Cancer: A Complex Association. In: Rath, P. (eds) Models, Molecules and Mechanisms in Biogerontology. Springer, Singapore. https://doi.org/10.1007/978-981-32-9005-1_21
Download citation
DOI: https://doi.org/10.1007/978-981-32-9005-1_21
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9004-4
Online ISBN: 978-981-32-9005-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)